Publications by authors named "T Salmen"
Pharmaceuticals (Basel)
October 2024
Article Synopsis
- This systematic review aims to compare the long-term cardiovascular protection of retatrutide and tirzepatide in patients with type 2 diabetes mellitus, focusing on recent data about tirzepatide's proven cardiovascular benefits.
- The review includes original research articles published within the last ten years, specifically randomized control trials involving adult human populations, while excluding studies based on animal models or those lacking sufficient data.
- The analysis of the seven selected studies suggests a potential cardiovascular benefit from diabetes treatments, but it highlights the need for longer follow-up studies to better understand these effects, especially in comparison with individuals without diabetes.
Curr Health Sci J
June 2024
Article Synopsis
- A retrospective study was conducted on 55 patients diagnosed with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) at The Clinical Emergency County Hospital Craiova, focusing on epidemiological and clinical aspects.
- The majority of patients were older adults, with a mean age of 66.4 years, and GEP-NETs were most commonly found in the colon, specifically the ascending colon.
- Notable findings included a higher prevalence of arterial hypertension in patients with colon neuroendocrine tumors (C-NET) and an overall increase in GEP-NET cases in recent years.
Pharmaceuticals (Basel)
September 2024
Article Synopsis
- The study examines the relationship between Type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) in Romanian patients, highlighting the effectiveness of antidiabetic drugs like GLP-1 Ras and SGLT-2 inhibitors.
- Conducted with 405 T2DM patients, the study found that while many achieved satisfactory blood sugar levels, they struggled to meet overall health targets including blood pressure and cholesterol management.
- Results indicated a high prevalence of comorbidities, particularly hypertension and obesity, and revealed a low usage of advanced treatments like GLP-1 Ras and SGLT-2 inhibitors, along with statins.
Article Synopsis
- - Diabetic neuropathy (DN) is a complex condition often underdiagnosed, and routine diagnostic tests like electrodiagnostic studies are rarely used in diabetes care, despite their importance in identifying neuropathies.
- - A study from a diabetes clinic in Romania examined seven type 2 diabetes patients, leading to the diagnosis of multiple entrapment neuropathies using electroneurography (ENG) and electromyography (EMG).
- - The findings suggest that electrodiagnosis is crucial for identifying focal neuropathies in diabetes patients and indicate that elevated skin autofluorescence (SAF) levels may be linked to the severity of symptoms, although larger studies are needed to confirm these results.
Article Synopsis
- The study investigates the long-term disability effects of severe COVID-19 three years after post-acute rehabilitation using the WHODAS 2.0 questionnaire.
- Out of 69 identified patients, only 27 participated, highlighting the impact of emotional distress on patient response rates; most patients were older, with comorbidities like diabetes and high blood pressure prevalent.
- Results showed a mean disability score of 35.09%, largely influenced by diabetes and central neurological deficits, suggesting a need for targeted rehabilitation and ongoing care to enhance recovery outcomes.
